Figure 6.
Azoles exhibit binding to only one or two out of the three binding sites in the ScPdr5p binding pocket. (A) Growth inhibition zones of the PDR5+ S. cerevisiae strain exposed to azoles, benchmark substrates of individual binding sites and their respective combinations. Stock solutions of azoles: clotrimazole (4.4 mM), miconazole (3.6 mM), bifonazole (1.6 mM), ketoconazole (7.6 mM) and itraconazole (4.2 mM). Stock solutions of benchmark substrates: rhodamine 6G (10 mM), TI (1 mM) and TBT (2.8 M). Asterisks highlight combinations of azoles and benchmark substrates leading to an enlargement of the growth-inhibition zones. (B) Schematic overview of the binding sites of tested azoles, fluorescent probe diS-C3(3) and benchmark substrates in the ScPdr5p binding pocket.

Azoles exhibit binding to only one or two out of the three binding sites in the ScPdr5p binding pocket. (A) Growth inhibition zones of the PDR5+ S. cerevisiae strain exposed to azoles, benchmark substrates of individual binding sites and their respective combinations. Stock solutions of azoles: clotrimazole (4.4 mM), miconazole (3.6 mM), bifonazole (1.6 mM), ketoconazole (7.6 mM) and itraconazole (4.2 mM). Stock solutions of benchmark substrates: rhodamine 6G (10 mM), TI (1 mM) and TBT (2.8 M). Asterisks highlight combinations of azoles and benchmark substrates leading to an enlargement of the growth-inhibition zones. (B) Schematic overview of the binding sites of tested azoles, fluorescent probe diS-C3(3) and benchmark substrates in the ScPdr5p binding pocket.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close